Comparison of Efficacy of 35% Glycolic Acid vs 20% Salicylic Acid Peel in the Treatment of Post Acne Scars
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of this clinical trial is to compare the effectiveness of two drugs in patients that presents with scars on face after acnes. The effectiveness will be measured by a goodman and baron scale. One group of patients will receive 35% glycolic acid while other group of patients will receive 20% salicylic acid and both groups will be followed by 12 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Apr 2025
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedFirst Submitted
Initial submission to the registry
April 17, 2025
CompletedFirst Posted
Study publicly available on registry
April 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedApril 24, 2025
March 1, 2025
6 months
April 17, 2025
April 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
improvement in acne scars as per Goodman and baron scale
6 months
Study Arms (2)
35% glycolic acid peel
EXPERIMENTAL20% salicylic acid
EXPERIMENTALInterventions
Chemical peel is a dermatological procedure in which chemical solution is applied to the skin to remove the top layer
Eligibility Criteria
You may qualify if:
- Patients aged 18-45 years with mild to moderate atrophic post acne scars
- Fitzpatrick skin type 2-4
- No active acne or ongoing systemic acne treatment
You may not qualify if:
- Pregnancy and breast feeding
- History of keloid or hypertrophic scars
- Use of retinoids or chemical peel in last 3 months
- Active skin infections
- History of hyperpigmentation after any procedure
- Hypersensitivity to aspirin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hayatabad Medical Complex
Peshawar, Kpk, 25130, Pakistan
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
khizar hayat, MBBS
Hayatabad Medical Complex Peshawar, KPK pakistan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor Dermatology unit HMC
Study Record Dates
First Submitted
April 17, 2025
First Posted
April 24, 2025
Study Start
April 1, 2025
Primary Completion
October 1, 2025
Study Completion
October 1, 2025
Last Updated
April 24, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share